Dr. Scott Pollack – Intracellular Enzyme Inhibitors in Small Drug Discovery

In conjunction with his presentation at the London Excel at ELRIG Drug Discovery 2018, Dr. Scott Pollack, Associate Director of Biophysics and Enzymology at Sygnature Discovery, was asked:

“Why are intracellular enzyme inhibitors used in small molecule drug discovery?”

Latest News

View All

Sygnature Discovery boosts growth of its In…

Sygnature Discovery Appoints New Chief Commercial Officer…

Sygnature Discovery appoints Rick Davies to spearhead…

Sygnature Discovery has Chosen Elsevier as New…